Your fact-checks will appear here
Clinical evidence and regulatory guidance show penile traction devices (PTDs) can produce modest, sometimes durable length gains and improve curvature in men with Peyronie’s disease when used consiste...
Randomized trials and systematic reviews show penile traction devices (PTDs) can reduce curvature in Peyronie’s disease and in some studies preserve or modestly increase penile length (e.g., +1.6 cm v...
Penile traction devices (PTDs) are non‑surgical tools used mainly to treat Peyronie’s disease (PD) and to limit length loss or erectile dysfunction after prostate surgery; randomized and meta‑analytic...
There are a small number of regulated, clinician‑used options that can change penile size: penile prostheses for erectile dysfunction are established FDA‑cleared devices, and at least one silicone cos...
Sustained adherence to penile traction therapy (PTT) over 12–24 months appears to be driven less by a single demographic trait than by a mix of clinical state, device burden (time/cost), and early pat...
Multi‑hour penile traction protocols historically required 3–8 hours daily and produced substantial drop‑off in real‑world use; early studies flagged prolonged wear as a core reason patients did not p...
Randomized trials have mostly tested newer-generation penile traction devices (notably RestoreX and Penimaster PRO) against no‑intervention controls and have also explored shorter daily wear times (30...
Medical societies and mainstream urology literature generally treat penile traction devices as a therapeutic option for specific medical conditions — especially Peyronie’s disease and post‑prostatecto...